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Introduction

Sarcoidosis is a granulomatous lung disease
that predisposes individuals to pulmonary
pathogens. Patients with sarcoidosis Stages
II-IV, and those with fibrocystic changes, are
at an increased risk for aspergillus infection.
Chronic pulmonary aspergillosis (CPA) can
complicate late-stage sarcoidosis, leading to
necrotizing granulomas, hemoptysis, and
potentially disseminated infection.

Case Report

A 37-year-old male with multiple exposures
presented with dyspnea, fever, and cough
productive of blood-streaked sputum for 5
months. Symptoms initially resolved with
levofloxacin, but later recurred and then
progressed. Imaging revealed bilateral
middle and lower lobe cavitary lung
lesions with fibrosis.
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Figure 1. Bilateral pulmonary infiltrates
and cavitary lesions on plain film.

Figure 2. Bilateral cavitary lung lesions
with surrounding fibrosis, atelectasis,
and bronchiectasis.

Pulmonary function tests revealed a
moderately-severe obstructive deficit.
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Two sputum fungal cultures grew Aspergillus
niger. Extensive serum testing including ANA,
ANCA, B-D-glucan, galactomannan, AFB/
quantiferon gold, cryptococcal antigen, and a
fungal antibody panel were negative. EBUS
transbronchial fine needle aspiration of node
station 11L and transbronchial biopsy with
bronchoalveolar lavage (BAL) of the left lower
lobe was performed. Node station 11L
revealed necrotizing granulomatous disease.
Bronchial fungal cultures, aspergillus antigen
and PJP were negative. Flow cytometry
samples were unremarkable. The patient
was treated with 4 months of voriconazole
and a prolonged steroid taper. Repeat
bronchoscopy revealed multiple necrotizing
and non-necrotizing granulomas in the right
upper lobe. All cultures were again negative.
Surgical right lower lobe wedge resection
demonstrated multiple non-necrotizing
granulomas that coalesced primarily along
the bronchovesicular bundles with prominent
fibrosis, suspicious for sarcoidosis. The
patient was then started on steroids and
trimethoprim-sulfamethoxazole, and then
maintained on hydroxychloroquine.

Discussion

CPA is a serious complication of sarcoidosis
that is associated with poor outcomes. Up
to 10% of patients with sarcoidosis develop
aspergillus infections. CPA should be
suspected in all patients with known lung
disease who have cavitary lung lesions for at
least three months, with direct evidence of
aspergillus infection. Over 50% of patients
have no visible aspergilloma on imaging.
If left unchecked, CPA can progress into
chronic fibrosing pulmonary aspergillosis.
The mechanism of injury is possibly due to
alveolar macrophage-induced free radical
damage. Laboratory testing often reveals
elevated serum aspergillus IgG levels;
however, the most definitive evidence is
positive direct microscopy or fungal cultures
from BAL. Patients often require lifelong
antifungal therapy, and extensive steroids.

Conclusion

This case highlights the importance of early
detection of aspergillus infections in patients
with known pulmonary disease, particularly
sarcoidosis. Early recognition and intervention
are crucial to avoid progressive fibrosis.

Figure 3. PFT’s reveal moderately-severe obstructive defect with decreased diffusion
capacity. A moderate restrictive defect is also present.
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